Jiuzhitang Co., Ltd. (SHE:000989)
China
· Delayed Price · Currency is CNY 9.74
-0.08 (-0.81%)
Apr 29, 2026, 3:04 PM CST
Jiuzhitang Revenue
In the year 2025, Jiuzhitang had annual revenue of 2.23B CNY, down -5.99%. Jiuzhitang had revenue of 601.80M in the quarter ending December 31, 2025, with 95.49% growth.
Revenue
2.23B
Revenue Growth
-5.99%
P/S Ratio
3.70
Revenue / Employee
606.77K
Employees
3,674
Market Cap
8.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.23B | -142.12M | -5.99% |
| Dec 31, 2024 | 2.37B | -589.64M | -19.91% |
| Dec 31, 2023 | 2.96B | -72.25M | -2.38% |
| Jan 1, 2023 | 3.03B | -750.89M | -19.84% |
| Jan 1, 2022 | 3.78B | 224.61M | 6.31% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KPC Pharmaceuticals,Inc. | 5.80B |
| Sichuan Huiyu Pharmaceutical | 1.03B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.14B |
| Guilin Sanjin Pharmaceutical | 2.08B |
| Shandong Lukang Pharmaceutical | 5.71B |
| Tianjin Ringpu Bio-Technology | 3.40B |
| Jiangsu Kanion Pharmaceutical | 3.29B |
| Chongqing Taiji Industry(Group) Co.,Ltd | 10.50B |